戊酸雌二醇片联合安宫黄体酮预防中重度宫腔粘连松解术后再次宫腔粘连的效果分析

Abstract
Figure/Table
References (22)
Related Citation (15)

Download: PDF (0 KB) HTML (39 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of Estradiol Valerate Tablets combined with Medroxyprogesterone in the prevention of intrauterine adhesion after moderate and severe intrauterine adhesion debonding.Methods A retrospective analysis of 64 patients with severe intrauterine adhesions in our hospital from January 2015 to December 2017 was divided into operation group (n=31)and combined group (n=33)according to different treatment method.Both groups underwent laparoscopic intrauterine adhesioslysis and placement of IUD after operation.The combination group was treated with Estradiol Valerate Tablets and progesterone.The duration of postoperative bleeding was compared between the two groups,bleeding and abdominal pain,cervical adhesions.Results The recurrence rate of intrauterine adhesions in the combined group was 19.35%,which was significantly lower than that in the operation group(41.94%)(P＜0.05）.The postoperative bleeding time,duration of abdominal pain,menstruation recovery time was shorter than that in the operation group,the bleeding volume was lesser than that in the operation group and endometrial thickness in the combined group were better than those in the operative group,the differences were statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups (P＞0.05）.Conclusion Estradiol Valerate and progesterone acetate can effectively prevent the occurrence of uterine adhesions and increase the incidence of uterine adhesions after moderate-to-severe intrauterine adhesions release without increasing the incidence of adverse reactions.

Key words： Intrauterine adhesions Progesterone Estradiol Valerate Hysteroscopy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	HUANG Yong-shen
	MENG Feng-ming

Cite this article:

HUANG Yong-shen,MENG Feng-ming. Efficacy of Estradiol Valerate combined with Medroxyprogesterone in preventing intrauterine adhesions after moderate to severe intrauterine adhesion[J]. 中国当代医药, 2018, 25(20): 72-74转90.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I20/72

[22]	林丽，文丽.雌激素联合安宫黄体酮片在宫腔镜手术治疗宫腔粘连中的应用效果[J].实用临床医学，2017，18（6）：63-64.
[1]	Guo J，Li TC，Liu Y，et al.A prospective，randomized，controlled trial comparing two doses of oestrogen therapy after hysteroscopic adhesiolysis to prevent intrauterine adhesion recurrence[J].Reprod Biomed Online，2017，35（5）：555-561.
[2]	蒋楠，邹一梅，张金风.两种雌激素治疗方案治疗宫腔粘连的前瞻性研究[J].山西医药杂志，2017，46（11）：1324-1326.
[3]	许凤.雌激素在宫腔粘连术后的应用研究[J].中国民康医学，2014，26（15）：58-59.
[4]	Riaz A，Zil-E-Ali A.Hysteroscopic Myomectomy can lead to intrauterine adhesions and infertility[J].Pak Med Assoc，2017，67（6）：964-965.
[5]	Gan L，Duan H，Xu Q，et al.Human amniotic mesenchymal stromal cell transplantation improves endometrial regeneration in rodent models of intrauterine adhesions[J].Cytotherapy，2017，19（5）：603-616.
[6]	Amin T，Saridogan E，Dooley M，et al.Morphological appearance of uterine cavity on ultrasound prior to development of intrauterineadhesions[J].Ultrasound Obstet Gynecol，2018，51（1）：142-143
[7]	王新侠.妇科内镜手术治疗重度宫腔粘连患者的护理[J].黑龙江医药科学，2017，40（1）：123-124.
[8]	林金芳，冯攒冲，丁爱华.实用妇科内镜学[M].上海：复旦大学出版社，2001：389-394.
[9]	孟芳.不同剂量雌激素对宫腔粘连电切术后子宫内膜修复的影响[J].中国实用医刊，2015，42（22）：100-101.
[10]	颜艳，杨桂春，郭碧辉.水囊联合不同剂量雌激素辅助治疗宫腔镜术后宫腔粘连的疗效、1年妊娠率及预后效果分析[J].中国妇幼保健，2017，32（14）：3340-3342.
[11]	罗雪娟.宫腔内持续放置水囊联合大剂量雌激素对宫腔粘连分离术后再粘连的预防价值[J].中国医药科学，2016，6（12）：66-68.
[12]	刘超斌，谢熙，苏彦钊.宫腔粘连术后留置玻璃酸钠联合大剂量雌激素预防再发粘连[J].生殖与避孕，2014，34（3）：210-214.
[13]	徐金焕.宫腔粘连分离术联合雌激素治疗宫腔粘连的疗效和安全性[J].实用妇科内分泌杂志（电子版），2017，4（23）：132.
[14]	Hooker AB，de Lee uw R，van de Ven PM，et al.Prevalence of intrauterine adhesions after the application of hyaluronic acid gel after dilatation and curettage in women with at least one previous curettage：short-term outcomes of a multicenter，prospective randomized controlled trial[J].Fertil Steril，2017，107（5）：1223-1231
[15]	Peng X，Li T，Zhao Y，et al.Safety and efficacy of amnion graft in preventing reformation of Intrauterine Adhesions[J].J Minim Invasive Gynecol，2017，24（7）：1204-1210.
[16]	龚翠梅，李丽琴，姚娟.补佳乐用于预防多次人流术后月经过少或闭经的疗效观察[J].中国实用医药，2014，（1）：182-183.
[17]	钟丽珍.不同剂量补佳乐用于宫腔粘连术后子宫内膜修复的疗效观察[J].中国当代医药，2017，24（31）：101-102.
[18]	张宁宁.不同雌激素用药方案对于重度宫腔粘连术后子宫内膜修复的影响[J].现代妇产科进展，2017，26（9）：701-703.
[19]	张小琴.人流术后口服补佳乐促进子宫内膜修复的临床分析[J].深圳中西医结合杂志，2014，24（6）：95-96.
[20]	吴幼丽.黄体酮和补佳乐对稽留流产清宫术后宫腔粘连的防治作用[J].中国妇幼保健，2016，31（11）：2357-2359.
[21]	周芹芳.稽留流产患者清宫术后应用补佳乐联合黄体酮治疗预防宫腔粘连的临床分析[J].中国妇幼保健，2014，29（33）：5448-5450.